Targeting the PI3K Pathway for Melanoma Brain Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
PI3K Pathway Inhibition Achieves Potent Antitumor Activity in Melanoma Brain Metastases in Vitro and in Vivo
Clin. Cancer Res 2016 Dec 01;22(23)5818-5828, H Niessner, J Schmitz, G Tabatabai, AM Schmid, C Calaminus, T Sinnberg, B Weide, TK Eigentler, C Garbe, B Schittek, L Quintanilla-Fend, B Bender, M Mai, C Praetorius, S Beissert, G Schackert, MH Muders, M Meinhardt, GB Baretton, R Dummer, K Flaherty, BJ Pichler, D Kulms, D Westphal, F MeierFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.